-
Mashup Score: 0
In this retrospective study, investigators highlight the effectiveness and safety of baricitinib and systemic corticosteroid addition for alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
These findings highlight the potential for JAKi use in alopecia areata in terms of associated neuroimmune dysregulation and comorbidities.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
NEW: JAK inhibitors may reduce neuroimmune dysregulation and psychiatric burdens in #AlopeciaAreata. 🔍 This study compared JAK inhibitors with immunosuppressants and corticosteroids. View: https://t.co/lsx8hOpoaD https://t.co/yxpw7UKLU6
-
-
Mashup Score: 2
These findings highlight the potential for JAKi use in alopecia areata in terms of associated neuroimmune dysregulation and comorbidities.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
NEW: JAK inhibitors may reduce neuroimmune dysregulation and psychiatric burdens in #AlopeciaAreata. 🔍 This study compared JAK inhibitors with immunosuppressants and corticosteroids. View: https://t.co/lsx8hOpoaD https://t.co/yxpw7UKLU6
-
-
Mashup Score: 3
In this analysis, investigators highlight the efficacy and safety of azathioprine as a monotherapy for those with recalcitrant and severe alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Azathioprine is an efficacious systemic treatment for patients living with recalcitrant and severe #AlopeciaAreata, according to recent findings. View more here: https://t.co/ALdTep01u4
-
-
Mashup Score: 2FDA Grants Fast Track Designation to Bempikibart for Alopecia Areata - 2 month(s) ago
This announcement by Q32 Bio Inc. highlights the Fast Track designation by the FDA granted to bempikibart (ADX-914) for alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
🚨NEW🚨 The FDA has granted Fast Track Designation to bempikibart for the treatment of patients with #AlopeciaAreata. Want to learn more? View our summary of the announcement... https://t.co/2fcORVxBQY https://t.co/dX0TzzoaBs
-
-
Mashup Score: 2FDA Grants Fast Track Designation to Bempikibart for Alopecia Areata - 2 month(s) ago
This announcement by Q32 Bio Inc. highlights the Fast Track designation by the FDA granted to bempikibart (ADX-914) for alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
🚨NEW🚨 The FDA has granted Fast Track Designation to bempikibart for the treatment of patients with #AlopeciaAreata. Want to learn more? View our summary of the announcement... https://t.co/2fcORVxBQY https://t.co/dX0TzzoaBs
-
-
Mashup Score: 0Experiences with JAK Inhibitors Highlighted Among Black Patients with Alopecia Areata - 2 month(s) ago
These data were the conclusion of a case series highlighting the experiences and responses of African American patients with alopecia areata who utilize JAK inhibitors.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
A case series points to a high rate of continued Janus Kinase (JAK) inhibitor utilization and positive treatment outcomes among patients with #AlopeciaAreata who identify as Black. View more on these findings: https://t.co/iSB5UeiPZ9 https://t.co/wFEuAkobrA
-
-
Mashup Score: 0Study Compares Efficacy of Monotherapies for Alopecia Areata, Including JAK Inhibitors - 3 month(s) ago
This network meta-analysis compares the relative effectiveness and safety of different monotherapies for patients living with alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
A new network meta-analysis has produced evidence on the comparative efficacy of #AlopeciaAreata monotherapies with different regimens of 8 Janus Kinase (JAK) inhibitors as well as dupilumab and apremilast. https://t.co/R2tfVmkwX5
-
-
Mashup Score: 1
This retrospective, real-world analysis highlights several notable findings on JAK inhibitor use among patients with alopecia areata.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
JAK inhibitors led to significant hair regrowth in #AlopeciaAreata patients, new data suggest, with 61% achieving substantial regrowth over a median follow-up of 16 months. View more here: https://t.co/3MffzaG1j7
-
-
Mashup Score: 0Epidemiology Associated With Alopecia Areata - 5 month(s) ago
Panelists discuss how the epidemiology of alopecia areata (AA) varies across different patient populations, with certain forms of the disease being more prevalent in specific groups.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet-
Amy McMichael, MD, from @wakeforestmed, discusses how #alopeciaareata (AA) affects diverse populations. Learn about the forms of AA most prevalent in clinical practice and hear insights shaping patient care. Watch now: https://t.co/SEZ7t4jR6o
-
New findings suggest that systemic corticosteroids, along with baricitinib, will enhance the drug’s efficacy in patients with severe #AlopeciaAreata and result in sustained benefits, particularly in partial responders. 🔗 View more on these data here: https://t.co/Kqdra2VBUZ